Last Updated: June 30, 2026

PERINDOPRIL Drug Patent Profile

Name: PERINDOPRIL Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Perindopril, and what generic alternatives are available?

Perindopril is a drug marketed by Ani Pharms, Apotex, Aurobindo Pharma, Hikma, and Lupin Ltd. and is included in five NDAs.

The generic ingredient in PERINDOPRIL is perindopril erbumine. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the perindopril erbumine profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Perindopril

A generic version of PERINDOPRIL was approved as perindopril erbumine by AUROBINDO PHARMA on November 10^th, 2009.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for PERINDOPRIL?
What are the global sales for PERINDOPRIL?
What is Average Wholesale Price for PERINDOPRIL?

Summary for PERINDOPRIL

US Patents:	0
Applicants:	5
NDAs:	5
DailyMed Link:	PERINDOPRIL at DailyMed

Drug patent expirations by year for PERINDOPRIL

US Patents and Regulatory Information for PERINDOPRIL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ani Pharms	PERINDOPRIL ERBUMINE	perindopril erbumine	TABLET;ORAL	078138-001	Nov 10, 2009		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Aurobindo Pharma	PERINDOPRIL ERBUMINE	perindopril erbumine	TABLET;ORAL	079070-001	Nov 10, 2009		RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Apotex	PERINDOPRIL ERBUMINE	perindopril erbumine	TABLET;ORAL	090463-001	Aug 30, 2010		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.